Dive into 3D object modeling and projectile motion with Python in Lesson 4! In this tutorial, we guide you step by step through creating 3D visualizations and simulating projectile motion using Python ...

https://www.thehindubusinessline.com/companies/dr-reddys-laboratories-q3-results-net-profit-slips-15-to-1189-cr/article70533294.ece Copy Dr Reddy’s Laboratories ...

Shares of Dr Reddy’s Laboratories surged over 4 percent in early trade on Thursday after the pharmaceutical company delivered a better-than-expected set of Q3 FY26 results, prompting brokerages to ...

Dr Reddy's Labs Q3 Results: Revenue from operations rose 4.4% to ₹8726.8 crore in the quarter under review compared with ₹8358.6 crore in Q3FY25. Dr Reddy's Labs Q3 Results: Dr Reddy's Laboratories ...

Mumbai: Dr. Reddy’s Laboratories reported a 14.4 percent year-on-year decline in consolidated net profit to Rs 1,210 crore in Q3 FY26, even as revenue grew 4.4 percent YoY to Rs 8,727 crore. The ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

Dr Reddy's Laboratories on Wednesday reported a 14 per cent decline in its consolidated net profit at Rs 1,209.8 crore for the third quarter ended December 31, 2025, weighed down by lower sales in its ...

On the daily scale, post correction from higher levels, Coforge was trading in a range-bound mode. However, it has delivered a range breakout along with decent volumes. Therefore, a close above the ...

Hyderabad (Telangana) [India], February 4 (ANI): Drugs Control Administration, Telangana, busted the unlicensed manufacturing and sale/distribution of medical devices at Bluesemi Research and ...

Hyderabad: Chief minister A Revanth Reddy on Sunday began an executive education programme at Harvard University's Kennedy School in Cambridge, Massachusetts, marking a rare academic engagement by a ...

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global ...